In his speech, the deputy health minister noted that for several years more therapies have been successively made available through drug lines.
- We issue new reimbursement decisions every two months to increase this availability. In recent years, we have often changed the content of drug programs to be in line with European guidelines and the characteristics of the medicinal product. We also often expand these reimbursement indications, in accordance with current medical knowledge and not necessarily with the SmPC. This is particularly evident when we transfer drug availability to the chemotherapy catalog. Such expansion occurs ex officio, after evaluation by the Agency for Health Technology Assessment and Tarification and experts: national consultants and scientific societies," Maciej Miłkowski pointed out.
On the othe...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
